| 发明名称 | Use of natriuretic peptide for treating heart failure | ||
| 摘要 | The present invention relates to the use of a natriurectic peptide, such as urodilatin, for treating a patient suffering from heart failure, such as acute decompensated heart failure. Preferably, a composition comprising an effective amount of urodilatin is intravenously administered to the patient continuously through a time period of at least 24 hours and up to 120 hours, preferably at least 48 hours. | ||
| 申请公布号 | US9358271(B2) | 申请公布日期 | 2016.06.07 |
| 申请号 | US201514632350 | 申请日期 | 2015.02.26 |
| 申请人 | Cardiorentis AG | 发明人 | Mitrovic Veselin;Luss Hartmut;Forssmann Wolf-Georg;Meyer Markus;Dohler Klaus |
| 分类号 | A61K47/26;A61K38/22 | 主分类号 | A61K47/26 |
| 代理机构 | Lowenstein Sandler LLP | 代理人 | Lowenstein Sandler LLP |
| 主权项 | 1. A method for treating acute decompensated heart failure (ADHF) or decompensated heart failure (DHF), comprising administering to a patient in need thereof a composition comprising an effective amount of urodilatin continuously for a time period ranging from 24 hours to 72 hours, wherein urodilatin is administered at a rate ranging from 7.5 ng/(kg·min) to about 100 ng/(kg·min). | ||
| 地址 | Zug CH | ||